Table 3 Results for empirical example
From: Stochastic cost-effectiveness analysis on population benefits
Population benefit (mean) | Population benefit (variance) | Return-to-risk | |
|---|---|---|---|
LMWH only | − 5612.00 | 2.55E+10 | − 0.035 |
Apixaban only | 14,556.00 | 2.72E+10 | 0.088 |
Rivaroxaban only | 13,778.00 | 2.53E+10 | 0.087 |
Edoxaban only | 13,632.00 | 2.44E+10 | 0.087 |
Equal weight mix | 9088.50 | 6.64E+09 | 0.112 |
Optimal structure | 13,981.95 | 8.87E+09 | 0.148 |